GlassScriptPhysician profile
Nathan L Judd
NPI 1376986281
$81,205.39
in general payments reported to CMS, 2019-2025
16 companies · $35K in 2025
The $35K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $1,148 · 2021: $65.40 · 2022: $1,354 · 2023: $3,676 · 2024: $39K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $75K · Travel and Lodging: $1,791 · Food and Beverage: $733 · Royalty Or License: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $75,218.00 |
| Travel and Lodging | $1,791.26 |
| Food and Beverage | $732.58 |
| Royalty Or License | $332.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forthright Medical - Mt, LLC | $69,534.40 | 2024-2025 | Truelok System, Ossiofiber Hammertoe Fixation System, Relja Reduction Clamp (Left and Right) |
| Gramercy Extremity Orthopedics LLC | $6,025.04 | 2022-2025 | |
| Avitus Orthopaedics, INC. | $1,543.14 | 2019-2020 | |
| Ossio INC | $1,500.00 | 2024 | |
| Vilex LLC | $1,189.80 | 2022 | |
| Orthofix Medical, INC. | $941.38 | 2025 | Truelok |
| Trilliant Surgical LLC. | $131.54 | 2019 | |
| In2bones USA, LLC | $105.40 | 2021-2022 | |
| Integra Lifesciences Corporation | $65.04 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Sioux Surgical INC | $47.91 | 2024-2025 | |
| Organogenesis INC. | $39.57 | 2020-2024 | |
| International Life Sciences | $26.32 | 2024 | Flexband |
| Nevro Corp. | $15.92 | 2022 | |
| Aroa Biosurgery Incorporated | $14.55 | 2022 | |
| Medline Industries LP | $14.00 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $11.38 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Judd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.